Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema (Q80967295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

E H Tschen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

A D Bucko

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

111-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema.

4 January 2020

cites work

1 reference

12 December 2020

Fluticasone propionate: safety profile.

1 reference

12 December 2020

Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream, 0.1%, in the treatment of moderate-to-severe psoriasis

1 reference

12 December 2020

The human pharmacology of fluticasone propionate

1 reference

12 December 2020

Topical corticosteroids in clinical practice: focus on fluticasone propionate.

1 reference

12 December 2020

A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema

1 reference

12 December 2020

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

12 December 2020

Fluticasone propionate in the treatment of inflammatory dermatoses

1 reference

12 December 2020

Efficacy and safety of fluticasone propionate 0.005% ointment in the treatment of psoriasis

1 reference

12 December 2020

Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema

1 reference

12 December 2020

The new corticosteroids: are they effective and safe?

1 reference

12 December 2020

Binding kinetics of fluticasone propionate to the human glucocorticoid receptor

1 reference

12 December 2020

Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.

1 reference

12 December 2020

10.2165/00044011-199816020-00003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18370528%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference